AviadoBio Ltd. ("AviadoBio") and Apertura Gene Therapy ("Apertura"), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced four presentations of new preclinical data at the ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
Language may feel like one of the most distinctly human things about you, but the genetic groundwork for it appears to be ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene W ...
The 23rd International Conference on Preimplantation Genetics commenced in Shanghai on Saturday, marking the first time that ...
Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...
Late-stage trial shows Intellia's one-time gene-editing therapy lonvoguran ziclumeran cut hereditary angioedema swelling ...
Scientists in Shanghai have identified a "brake" gene that could potentially halt the progression of Alzheimer's disease, ...
A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...
Opinion
15hon MSNOpinion
Intellia's gene therapy effective in cutting swelling attacks in rare disease trial
April 27 (Reuters) - Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in patients with a rare genetic disorder in a late-stage trial ...
Industry’s First Combination BCMA x GPRC5D In Vivo CAR T Cell Therapy for the Treatment of Multiple Myeloma - SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results